LTR Pharma Limited (AU:LTP)
ASX:LTP
Australian Market
Holding AU:LTP?
Track your performance easily

LTR Pharma Limited (LTP) Technical Analysis

9 Followers

Summary of all the Indicators

Overall Consensus
Buy
10Bullish
6Neutral
4Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Buy
8Bullish
0Neutral
2Bearish
LTR Pharma Limited’s (LTP) Moving Averages Convergence Divergence (MACD) indicator is 0.11, suggesting LTR Pharma Limited is a Buy.
LTR Pharma Limited’s (LTP) 20-Day exponential moving average is 1.62, while LTR Pharma Limited’s (LTP) share price is AU$1.78, making it a Buy.
LTR Pharma Limited’s (LTP) 50-Day exponential moving average is 1.34, while LTR Pharma Limited’s (LTP) share price is AU$1.78, making it a Buy.

LTR Pharma Limited (LTP) Pivot Points

Sep 20, 2024, 09:40 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.33
1.40
1.51
1.58
1.68
1.75
1.86
Fibonacci
1.40
1.47
1.51
1.58
1.64
1.68
1.75
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

LTR Pharma Limited (LTP) Moving Averages

Sep 20, 2024, 09:40 AM
Period
Simple
Exponential
MA5
1.65Buy
1.66Buy
MA10
1.70Sell
1.68Buy
MA20
1.73Sell
1.62Buy
MA50
1.25Buy
1.34Buy
MA100
0.92Buy
1.05Buy
LTR Pharma Limited’s (LTP) 10-Day exponential moving average is 1.68, while LTR Pharma Limited’s (LTP) share price is AU$1.78, making it a Buy.
LTR Pharma Limited’s (LTP) 100-Day exponential moving average is 1.05, while LTR Pharma Limited’s (LTP) share price is AU$1.78, making it a Buy.
LTR Pharma Limited’s (LTP) stock price is AU$1.78 and LTR Pharma Limited’s (LTP) 50-day simple moving average is 1.25, creating a Buy signal.
LTR Pharma Limited’s (LTP) stock price is AU$1.78 and LTR Pharma Limited’s (LTP) 100-day simple moving average is 0.92, creating a Buy signal.

LTR Pharma Limited (LTP) Technical Indicators

Sep 20, 2024, 09:40 AM
Name
Value
Implied Action
RSI (14)
56.93
Neutral
STOCH (9,6)
36.51
Neutral
STOCHRSI (14)
23.23
Neutral
MACD (12,26)
0.11
Buy
ADX (14)
47.50
Neutral
Williams %R
-63.64
Buy
CCI (14)
-77.67
Neutral
ATR (14)
0.16
-
Ultimate Oscillator
41.68
Neutral
ROC
-4.52
Sell
LTR Pharma Limited’s (LTP) Relative Strength Index (RSI) is 56.93, creating a Neutral signal.
LTR Pharma Limited’s (LTP) Trend Strength Indicator (ADX) is 47.50, creating a Neutral signal.
LTR Pharma Limited’s (LTP) Commodity Channel Index (CCI) is -77.67, creating a Neutral signal.
LTR Pharma Limited’s (LTP) Price Rate of Change (ROC) is -4.52, creating a Sell signal.

FAQ

Is LTP a Buy, Hold, or Sell?
Based on LTP’s technical indicators, LTP is a Buy.
    What is LTP’s RSI (14)?
    LTP’s RSI (14) is 56.93, which suggests LTP is a Neutral.
      What is LTP’s MACD?
      LTP’s MACD is 0.11, which suggests LTP is a Buy.
        What is LTP’s 5-day moving average?
        LTP’s 5-day moving average is 1.65, which suggests LTP is a Buy.
          What is LTP’s 20-day moving average?
          LTP 20-day moving average is 1.73, which suggests LTP is a Sell.
            What is LTP’s 50-day moving average?
            LTP’s 50-day moving average is 1.25, which suggests LTP is a Buy.
              What is LTP’s 200-day moving average?
              Currently, no data Available
              What is LTP’s Williams % R (14)?
              LTP’s Williams % R (14) is -63.64, which suggests LTP is a Buy.
                What is LTP’s CCI (14)?
                LTP’s CCI (14) is -77.67, which suggests LTP is a Neutral.
                  What is the share price of LTR Pharma Limited?
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis